Purgo Scientific, a medical device company focused on drug delivery technologies, has named James A. Bowman as its CEO. Founded in 2017, Purgo is located in South Jordan.
Bowman has over 20 years of experience leading early-stage life science companies and commercializing medical and surgical technologies. He has a background in biomedical engineering and executive training from Harvard Business School’s Owner/President Management program. He has raised venture capital and institutional funding and launched products across a wide range of specialties, including general surgery, orthopedics, neurosurgery, cardiothoracic, gynecology, imaging, and oncology.
Bowman succeeds Mike Benjamin, who has stepped down for personal health reasons. Benjamin will remain actively involved in the company as chairman of the board.
“Jim is exactly the kind of leader we need at this pivotal stage of our growth,” said Benjamin. “His proven ability to bring novel surgical and drug delivery technologies to market, combined with a strong track record of operational excellence, makes him an ideal fit to lead Purgo into its next chapter.”
“I’m honored to join Purgo Scientific and build on the strong foundation Mike and the team have created,” said Bowman. “With Purgo’s unique platform technology and strong scientific underpinnings, we have the opportunity to improve patient outcomes and set a new standard of care in localized therapy.”